Evaluating Procedural Performance: A Composite Outcome for Atrial Septal Defect and Patent Ductus Arteriosus Closures

Oliver M. Barry MD , Babar S. Hasan MBBS , Nadeem Aslam MBBS , Sarosh P. Batlivala MD, MSCI , Matthew A. Crystal MD , Sara M. Trucco MD , Todd Gudausky MD , Ralf J. Holzer MD , Jacqueline Kreutzer MD , George Nicholson MD , Michael L. O’Byrne MD, MSCE , Brian P. Quinn MD , Surendranath R. Veeram Reddy MD , Arash Salavitabar MD , Brian A. Boe MD
{"title":"Evaluating Procedural Performance: A Composite Outcome for Atrial Septal Defect and Patent Ductus Arteriosus Closures","authors":"Oliver M. Barry MD ,&nbsp;Babar S. Hasan MBBS ,&nbsp;Nadeem Aslam MBBS ,&nbsp;Sarosh P. Batlivala MD, MSCI ,&nbsp;Matthew A. Crystal MD ,&nbsp;Sara M. Trucco MD ,&nbsp;Todd Gudausky MD ,&nbsp;Ralf J. Holzer MD ,&nbsp;Jacqueline Kreutzer MD ,&nbsp;George Nicholson MD ,&nbsp;Michael L. O’Byrne MD, MSCE ,&nbsp;Brian P. Quinn MD ,&nbsp;Surendranath R. Veeram Reddy MD ,&nbsp;Arash Salavitabar MD ,&nbsp;Brian A. Boe MD","doi":"10.1016/j.jscai.2024.102459","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Technical success (TS) and procedural safety (PS) have been reported individually for transcatheter atrial septal defect (ASD) and patent ductus arteriosus (PDA) closures. A composite procedural performance (PP) metric as a patient-centered strategy has not been developed or studied.</div></div><div><h3>Methods</h3><div>A multicenter expert working group created PP metrics for ASD and PDA device closures as a composite of TS and PS. TS criteria were defined and categorized into 3 classes (optimal, satisfactory, and unsatisfactory). PS was defined using established adverse event (AE) definitions from the Congenital Cardiac Catheterization Project on Outcomes (C3PO) registry. PP was divided into 3 outcome classes (I to III). Retrospective C3PO data were collected for all cases of isolated ASD and PDA closure from 2014 through 2017. Exclusion criteria included complex congenital heart disease, significant comorbidities, ASD patients with multiple defects or ≥2 deficient rims, and PDA patients weighing &lt;6 kg or with pulmonary hypertension. Factors correlating with class III (suboptimal) PP were analyzed.</div></div><div><h3>Results</h3><div>A total of 542 ASD and 688 PDA closure cases were included. Most ASD cases (99%) had optimal or satisfactory TS while 1% had a high severity AE. Class III PP occurred in 2% of ASD cases, mostly due to new mitral valve insufficiency. There were no identified patient or procedural factors associated with class III PP for ASD closures. Optimal or satisfactory TS occurred in 98% of PDA cases, with high severity AEs in &lt;1%. Class III PP occurred in 2% of PDA cases, predominantly due to new arch obstruction, and was associated with younger age (<em>P</em> &lt; .001) and lower weight (<em>P</em> = .001).</div></div><div><h3>Conclusions</h3><div>This study introduces PP as a composite variable to comprehensively measure outcomes of standard-risk ASD and PDA device closure. The incorporation of both TS and PS aims to better reflect patient outcomes compared to individual measurements alone. PP may serve as a valuable tool for identifying areas for further investigation and quality improvement.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 2","pages":"Article 102459"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Society for Cardiovascular Angiography & Interventions","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772930324021483","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Technical success (TS) and procedural safety (PS) have been reported individually for transcatheter atrial septal defect (ASD) and patent ductus arteriosus (PDA) closures. A composite procedural performance (PP) metric as a patient-centered strategy has not been developed or studied.

Methods

A multicenter expert working group created PP metrics for ASD and PDA device closures as a composite of TS and PS. TS criteria were defined and categorized into 3 classes (optimal, satisfactory, and unsatisfactory). PS was defined using established adverse event (AE) definitions from the Congenital Cardiac Catheterization Project on Outcomes (C3PO) registry. PP was divided into 3 outcome classes (I to III). Retrospective C3PO data were collected for all cases of isolated ASD and PDA closure from 2014 through 2017. Exclusion criteria included complex congenital heart disease, significant comorbidities, ASD patients with multiple defects or ≥2 deficient rims, and PDA patients weighing <6 kg or with pulmonary hypertension. Factors correlating with class III (suboptimal) PP were analyzed.

Results

A total of 542 ASD and 688 PDA closure cases were included. Most ASD cases (99%) had optimal or satisfactory TS while 1% had a high severity AE. Class III PP occurred in 2% of ASD cases, mostly due to new mitral valve insufficiency. There were no identified patient or procedural factors associated with class III PP for ASD closures. Optimal or satisfactory TS occurred in 98% of PDA cases, with high severity AEs in <1%. Class III PP occurred in 2% of PDA cases, predominantly due to new arch obstruction, and was associated with younger age (P < .001) and lower weight (P = .001).

Conclusions

This study introduces PP as a composite variable to comprehensively measure outcomes of standard-risk ASD and PDA device closure. The incorporation of both TS and PS aims to better reflect patient outcomes compared to individual measurements alone. PP may serve as a valuable tool for identifying areas for further investigation and quality improvement.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估手术性能:房间隔缺损和动脉导管未闭的综合结果
背景:经导管房间隔缺损(ASD)和动脉导管未闭(PDA)封闭术分别有技术成功(TS)和程序安全(PS)的报道。作为以患者为中心的策略,复合程序性能(PP)指标尚未被开发或研究。方法一个多中心专家工作组创建了ASD和PDA设备闭合的PP指标,作为TS和PS的复合,定义了TS标准,并将其分为3类(最佳、满意和不满意)。PS的定义采用先天性心导管置入术预后项目(C3PO)注册表中已建立的不良事件(AE)定义。PP分为3个结局类别(I至III)。回顾性C3PO数据收集了2014年至2017年所有孤立性ASD和PDA闭合病例。排除标准包括复杂先天性心脏病、显著合并症、ASD患者有多个缺陷或≥2个缺陷边缘、PDA患者体重6kg或合并肺动脉高压。分析与III类(次优)PP相关的因素。结果共纳入ASD 542例,PDA闭合688例。大多数ASD病例(99%)有最佳或满意的TS,而1%有严重的AE。ii级PP发生在2%的ASD病例中,主要是由于新的二尖瓣不全。没有确定的患者或程序因素与ASD闭合的III级PP相关。98%的PDA患者出现最佳或满意的TS, 1%的患者出现严重ae。III级PP发生在2%的PDA病例中,主要是由于新的弓阻塞,并且与年轻有关(P <;.001)和更低的体重(P = .001)。结论本研究引入PP作为复合变量,综合衡量标准风险ASD和PDA设备闭合的结局。与单独的个体测量相比,TS和PS的结合旨在更好地反映患者的结果。PP可以作为确定需要进一步调查和质量改进的领域的有价值的工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
0
审稿时长
48 days
期刊最新文献
The Evolution of Carotid Stenting-From Reason to Reality. Perfect Matchmaking: A Deep Dive Into the Interventional Cardiology Fellowship Match 2025. Combined, Back-to-Back Endovascular Thrombectomy for Extensive Deep Vein Thrombosis: A Case Report. Management of Right-Sided Cardiac Masses With Manual Aspiration Using AlphaVac Device: A Single-Center Case Series. Flow Gradients in Severe Aortic Stenosis and Preserved Ejection Fraction: A 10-Year Transcatheter Aortic Valve Replacement Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1